Male Factor Infertility test has been upgraded from targeted mutation analysis to NGS panel with 60 genes associated with spermatogenic failure and meiotic arrest. Testing for Klinefelter syndrome and AZF deletions is also available. Visit www.asperbio.com/male-factor-infertility to see the full list of genes.
Our latest release is a panel of Congenital Disorders of Glycolysation targeting pathogenic variants in 49 clinically relevant genes. List of genes with more detailed information is available www.asperbio.com/congenital-disorders-of-glycolysation/
Genetic testing for Kallmann Syndrome is now available. New gene panel consists of 25 carefully selected genes and includes detection of single nucleotide polymorphisms (SNPs), insertions and deletions, as well as copy number variations (CNVs). Discover more at www.asperbio.com/asper-endocrinology/kallmann-syndrome-ngs-panel/
Dystonia and Spinocerebellar Ataxia panels are updated with MECR gene. Visit www.asperbio.com/asper-neurogenetics/ to learn more!
Prostate Cancer panel has been updated with 3 new genes. View the full list of genes www.asperbio.com/prostate-cancer-ngs-panel/
Updated versions of Vitreoretinopathy and comprehensive Eye Diseases NGS panels are now available. Order here www.asperbio.com/Asper_Ophthalmics_order_form
We have launched Asper Nephrology testing portfolio to expand our testing menu and cover more clinical areas. The new portfolio includes tests for common monogenic diseases, as well as complex disorders. To establish the genetic cause of renal diseases we use next-generation sequencing technology to accommodate a broad differential diagnosis. CNV analysis based on sequencing data is also available to enhance precise diagnosis. Visit https://www.asperbio.com/asper-nephrology/ to see the full list of tests.
We have integrated copy number variation (CNV) detection tool into our everyday workflow. CNV analysis is now available as a new testing option for all NGS panels and whole exome sequencing.
View the complete list of all tests www.asperbio.com/genetic-tests/
Asper Neurogenetics testing portfolio has been updated with Brunner syndrome test, and CNV analysis for all gene panels. See complete Asper Neurogenetics test menu here https://www.asperbio.com/asper-neurogenetics/
All NGS panels in Asper Otogenetics testing menu now include CNV analysis. Read more at www.asperbio.com/asper-otogenetics/
We now offer an NGS panel for Hereditary Hemorrhagic Telangiectasia. Additionally, Noonan Syndrome test has been upgraded to Noonan Spectrum Disorders/Rasopathies test including several new disease-causing genes. All NGS panels in Asper Cardiogenetics testing menu are covered by CNV analysis based on sequencing data. Visit https://www.asperbio.com/asper-cardiogenetics/ to learn more.
We have updated our Asper Oncogenetics menu. Genetic testing for Prostate Cancer is now available. The testing includes sequencing of the panel of genes and CNV analysis. Other NGS panels in the Asper Oncogenetics menu now also include CNV analysis. View our updated pricelist at www.asperbio.com/Asper Oncogenetics
We are pleased to announce that our NGS panels now include CNV analysis.
In addition, three new genes have been added to the Bardet-Biedl Syndrome panel.
Visit www.asperbio.com/asper-ophthalmics to learn more about our new testing options and see the updated price list.
We have added 14 new disease-causing genes to our spinocerebellar ataxia panel. Discover more at www.asperbio.com/spinocerebellar-ataxia/
NGS panel for Ectopia Lentis is now available. Visit www.asperbio.com/ectopia-lentis to read more.
We have updated several neurological panels, including Charcot-Marie-Tooth Disease, Frontotemporal Dementia, and Parkinson’s Disease. Please see https://www.asperbio.com/asper-neurogenetics/ for more information.
We have launched an updated Asper Neurogenetics menu. Genetic testing for Congenital Myasthenic Syndrome is now available, as well as updated version of Epilepsy panel. Learn more at www.asperbio.com/asper-neurogenetics
We have added a panel of Coagulation Disorders to our testing menu. The test consists of 17 genes associated with a wide variety of coagulation abnormalities. More details can be found www.asperbio.com/coagulation-disorders
Von Hippel-Lindau Disease testing by sequencing of the VHL gene is now available. Please see www.asperbio.com/von-hippel-lindau-disease/ for more information.
We are proud to announce a brand new testing menu – Asper Dermatology, which includes gene panels targeting the diagnostics of different skin related inherited disorders. New panels also facilitate differential diagnosis of diseases with overlapping features. Visit www.asperbio.com/asper-dermatology/ to find out more.
We have launched a panel of 20 genes to test for Osteogenesis Imperfecta and a panel of 3 genes for Frazer Syndrome testing. Find more at www.asperbio.com/asper-dysmorphology
Genetic testing for primary ciliary dyskinesia is now available. The test includes analysis of 35 genes associated with different types of disease. Read more at www.asperbio.com/primary-ciliary-dyskinesia
Asper Ophthalmics testing menu has been updated with Senior-Loken Syndrome gene panel. We have also added a number of genes to Cone-Rod Dystrophy, Vitelliform Macular Dystrophy, and comprehensive eye diseases panels. Comprehensive eye diseases panel now covers 283 genes associated with different eye disorders. View updated testing options at www.asperbio.com/asper-ophthalmics/
We have added Ehlers-Danlos Syndrome panel to our Asper Cardiogenetics testing menu. In addition, Noonan Syndrome panel has been updated with LZTR1 gene. For more information visit us at www.asperbio.com/asper-cardiogenetics/
Asper Biogene has added 10 new genes to the Parkinson’s Disease gene panel. Now the NGS panel consists of 32 disease related genes. Learn more about genes and conditions covered by the test at www.asperbio.com/parkinson-disease
Updated version of Hypertrophic Cardiomyopathy gene panel is now available. Learn more about added genes and related conditions at www.asperbio.com/hypertrophic-cardiomyopathy/NGS-panel
Metabolic Myopathy and Rhabdomyolysis NGS panel has been updated with the SCN4A gene. View full list of genes at www.asperbio.com/metabolic-myopathy-and-rhabdomyolysis/
Cancer Predisposition NGS panel has been updated with 10 new genes. For the complete list of genes please visit www.asperbio.com/cancer-predisposition
We will be attending the 4th Congress of the European Academy of Neurology in Lisbon, 16-19 June. Do not miss the opportunity to get informed about recent developments and news in clinical neurology. Stop by the exhibition hall to learn about Asper Neurogenetics tests and get acquainted with our experts. Looking forward to meeting you at booth #C24!
We have updated Cornelia de Lange Syndrome NGS panel with four new genes. Learn more at www.asperbio.com/cornelia-de-lange-syndrome
We have updated Parkinson’s disease NGS panel with two new genes. Del/dup analysis is also available. For detailed testing options visit www.asperbio.com/asper-neurogenetics/parkinson-disease
Comprehensive Limb-Girdle Muscular Dystrophy (LGMD) test is now available. The new test enables detection of disease-causing variants by sequencing of a multigene panel and deletion/duplication analysis. Various subtypes of LGMD are covered by the analysis, visit https://www.asperbio.com/asper-neurogenetics/limb-girdle-muscular-dystrophy-ngs-panel/ to find out complete testing information.
Del/dup analysis can now be ordered in addition to NGS panels. Read more about upgraded testing options at each portfolio or see the price list www.asperbio.com/Asper-Biogene-price-list. Feel free to contact us if there are any additional genes you would need to be included in the analysis.
Vitreoretinopathy NGS panel with 19 genes has been added to Asper Ophthalmics testing portfolio. Read more about genes and diseases covered by the panel on www.asperbio.com/vitreoretinopathy
Hereditary Sideroblastic Anemia NGS panel is now available. View genes and diseases covered by the panel on https://www.asperbio.com/hereditary-sideroblastic-anemia
Leukodystrophy and Leukoencephalopathy NGS panel of 40 genes is now available. View full list of genes www.asperbio.com/eukodystrophy-and-leukoencephalopathy
Congenital Myopathy and Distal Myopathy NGS panel has been added to Asper Neurogenetics portfolio. The new panel includes analysis of 43 genes linked to numerous types of myopathy. Learn more about test www.asperbio.com/congenital-myopathy-and-distal-myopathy
We would be very grateful for any comments on whether this panel can enhance your testing activities or additional genes/conditions should be involved in the panel. Contact us at info[at]asperbio.com and give your feedback.
All our catalogue prices will be reduced by 10% for the next two months. Use the great opportunity and make sure to place your order before January 31, 2018.
Asper Biogene is pleased to introduce our new testing portfolio of metabolic disorders. Single gene tests as well as multigene panels are included in Asper Metabolic Disorders’ menu. Glycogen and lysosomal storage diseases, fatty acid oxidation disorders, and urea cycle disorders are represented among others.
Full list of tests is available on www.asperbio.com/asper-metabolic-disorders
We have expanded our selection of cardiovascular genetic tests to include tests for different types of dyslipidemias, cardiomyopathies, and arrhythmias. In addition, pulmonary arterial hypertension test has been upgraded with a set of genes to facilitate differential diagnosis. Full list of tests is available: www.asperbio.com/asper-cardiogenetics/